PCM
ELOS

Penn Capital Management’s Syneron Medical Ltd ELOS Stock Holding History

Penn Capital Management’s Portfolio ELOS Stock Details ELOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-54,789
Closed -$682K – 311
2014
Q1 		$682K Sell
54,789
-139,804
-72% -$1.66M 0.03% 271
2013
Q4 		$2.39M Sell
194,593
-152,965
-44% -$1.59M 0.09% 226
2013
Q3 		$3M Buy
347,558
+9,684
+3% +$83.6K 0.12% 198
2013
Q2 		$2.94M Buy
+337,874
New +$3.02M 0.12% 215

Other funds holding ELOS

BG
Baupost Group Boston, Massachusetts $5.12B AUM 15.99% 1-Year Est. Return
SM
Senvest Management New York $3.01B AUM 35.7% 1-Year Est. Return
VAM
Visium Asset Management New York $1.43B AUM 3.58% 1-Year Est. Return
NTC
North Tide Capital Boston, Massachusetts $469M AUM 6.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BIP
Brandes Investment Partners La Jolla, California $14.1B AUM 25.52% 1-Year Est. Return
BC
Broadfin Capital New York $747M AUM 100.56% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
HC
Hourglass Capital Houston, Texas $480M AUM 32.35% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Penn Capital Management's ELOS Position: Q2 2014 in Review

Penn Capital Management sold out of Syneron Medical Ltd (ELOS) in Q2 2014, closing a stake of 54,789 shares — an estimated $682K sold.

Penn Capital Management first reported a position in ELOS in Q2 2013 and held it in 4 quarters. The position peaked at $3M in Q3 2013. 61 funds tracked by Wall St. Rank hold ELOS as of Q2 2014.

  • Penn Capital Management reported no remaining Syneron Medical Ltd position as of Q2 2014 after selling out during the quarter.
  • Penn Capital Management sold 54,789 Syneron Medical Ltd shares in Q2 2014, an estimated $682K.
  • Penn Capital Management first reported a position in Syneron Medical Ltd in Q2 2013 and held it in 4 quarters.
  • Penn Capital Management's Syneron Medical Ltd position peaked at $3M in Q3 2013.
  • 61 funds tracked by Wall St. Rank held Syneron Medical Ltd as of Q2 2014.

Based on Penn Capital Management's 13F filing for Q2 2014, filed 12 Aug 2014.